Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide
2012 · Leukemia · 783 citations
https://doi.org/10.1038/leu.2012.119
R
Rajesh Chopra
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
277
Papers
15.4K
Citations
59
h-index
117
i10-index
Rajesh Chopra is an academic researcher from Io Therapeutics (United States). The author has contributed to research in topics: Protein Degradation and Inhibitors & Multiple Myeloma Research and Treatments & Lymphoma Diagnosis and Treatment. The author has an h-index of 59, co-authored 236 publications.
Papers by this author
worksTransforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis
2014 · Nature Medicine · 425 citations
https://doi.org/10.1038/nm.3512
Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice
1996 · The Journal of Immunology · 209 citations
https://doi.org/10.4049/jimmunol.157.8.3216
Single-Cell Phosphoproteomics Resolves Adaptive Signaling Dynamics and Informs Targeted Combination Therapy in Glioblastoma
2016 · Cancer Cell · 164 citations
https://doi.org/10.1016/j.ccell.2016.03.012
Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
2015 · Cancer Chemotherapy and Pharmacology · 116 citations
https://doi.org/10.1007/s00280-015-2833-5
Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus
2018 · Annals of the Rheumatic Diseases · 77 citations
https://doi.org/10.1136/annrheumdis-2017-212916
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat